• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BNO
Click for more information
5.26% 20.0¢

BIONOMICS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BNO Becoming a substantial holder (revised form)08/06/17
BNO Becoming a substantial holder08/06/17
BNO Ceasing to be a substantial holder07/06/17
BNO Bionomics Corporate Presentation May 2017PRICE SENSITIVE31/05/17
BNO Bionomics NOW Newsletter May 201729/05/17
BNO Bionomics Recruits International Executive as CFO24/05/17
BNO BNC210 Clinical Data Presented at US Psychiatry ConventionPRICE SENSITIVE18/05/17
BNO Bionomics to Host KOL Meeting Focused on BNC210 in London10/05/17
BNO Appendix 4C - quarterlyPRICE SENSITIVE26/04/17
BNO Bionomics Presents Promising BNC101 Data at AACR Conference03/04/17
BNO Webcast Available of KOL Meeting24/03/17
BNO Bionomics to Host KOL Meeting on PTSD & Anxiety in New York20/03/17
BNO Appendix 3B13/03/17
BNO Bionomics to Present at 29th Annual ROTH Conference10/03/17
BNO Ceasing to be a substantial holder from CVC24/02/17
BNO Change in substantial holding24/02/17
BNO Becoming a substantial holder24/02/17
BNO Change in substantial holding24/02/17
BNO New BNC105 Clinical Trial in Combination with KeytrudaPRICE SENSITIVE20/02/17
BNO Half Yearly Report and AccountsPRICE SENSITIVE17/02/17
BNO MSD Cognition Program Milestone PaymentPRICE SENSITIVE03/02/17
BNO Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
BNO Bionomics Presents at Biotech Showcase 201709/01/17
BNO Appendix 3B12/12/16
BNO Warrants Update12/12/16
BNO Change of Director's Interest Notice28/11/16
BNO Change of Director's Interest Notice28/11/16
BNO Change of Director's Interest Notice28/11/16
BNO Change of Director's Interest Notice28/11/16
BNO Change of Director's Interest Notice28/11/16
BNO Appendix 3B28/11/16
BNO Appendix 3B16/11/16
BNO BNO to Present at Society for Neuroscience Annual Meeting16/11/16
BNO Final Director's Interest Notice10/11/16
BNO Results of Meeting08/11/16
BNO CEO & Managing Director's Report to ShareholdersPRICE SENSITIVE08/11/16
BNO Chairman's Address Bionomics Annual General Meeting 201608/11/16
BNO Appendix 3B04/11/16
BNO Bionomics and MSD Annual Symposium04/11/16
BNO Appendix 4C - quarterly-BNO.AX PRICE SENSITIVE31/10/16
BNO BNO to Present at International Biotechnology Symposium-BNO.AX 25/10/16
BNO Upcoming Investor Presentations-BNO.AX 24/10/16
BNO Appendix 4G / Corporate Governance Statement-BNO.AX 07/10/16
BNO Bionomics Annual Report 2016-BNO.AX 07/10/16
BNO Notice of General Meeting/Proxy Form-BNO.AX 07/10/16
BNO Change of Director's Interest Notice-BNO.AX 06/10/16
BNO Appendix 3B-BNO.AX 06/10/16
BNO BNO to Present at Ladenburg Thalmann Healthcare Conference-BNO.AX 26/09/16
BNO BNO BNC210 GAD Trial Results Investor Call Replay-BNO.AX 22/09/16
BNO Positive BNC210 Phase 2 Anxiety Trial Results-BNO.AX PRICE SENSITIVE21/09/16
BNO Trading Halt-BNO.AX PRICE SENSITIVE19/09/16
BNO BNC210 Data to be Presented at ECNP-BNO.AX PRICE SENSITIVE16/09/16
BNO Change of Director's Interest Notice-BNO.AX 15/09/16
BNO BNO to Present at Rodman & Renshaw Global Investment Conf.-BNO.AX 12/09/16
BNO Change of Director's Interest Notice-BNO.AX 01/09/16
BNO Final Director's Interest Notice-BNO.AX 01/09/16
BNO Initial Director's Interest Notice-BNO.AX 01/09/16
BNO Bionomics Appoints Alan Fisher Non-Executive Director-BNO.AX 31/08/16
BNO Change in substantial holding-BNO.AX 28/08/16
BNO Change in substantial holding-BNO.AX 26/08/16
BNO Appendix 3B-BNO.AX 19/08/16
BNO Appendix 3Y-BNO.AX 19/08/16
BNO Change of Director's Interest Notice-BNO.AX 17/08/16
BNO Withdrawal of Intention to Call General Meeting,CVC-BNO.AX 15/08/16
BNO Board Changes and Conclusion of Governance Review-BNO.AX 09/08/16
BNO Full Year Statutory Accounts-BNO.AX 09/08/16
BNO Bionomics 2015/2016 Preliminary Final Results-BNO.AX PRICE SENSITIVE09/08/16
BNO Board and Shareholder Meetings-BNO.AX 03/08/16
BNO Appendix 4C - quarterly-BNO.AX PRICE SENSITIVE29/07/16
BNO Bionomics to present at upcoming US Investor Conference-BNO.AX 12/07/16
BNO Final Director's Interest Notice-BNO.AX 08/07/16
BNO Appendix 3B-BNO.AX 04/07/16
BNO Director Retirement and Informal Board-Shareholder Meetings-BNO.AX 04/07/16
BNO Appendix 3B-BNO.AX 30/06/16
BNO BNO To Trial Drug Against Post-Traumatic Stress Disorder-BNO.AX PRICE SENSITIVE30/06/16
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX PRICE SENSITIVE24/06/16
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX PRICE SENSITIVE24/06/16
BNO Bionomics Receives Share of Funds from CTx License Deal-BNO.AX PRICE SENSITIVE23/06/16
BNO Initial Director's Interest Notice-BNO.AX 21/06/16
BNO Initial Director's Interest Notice-BNO.AX 21/06/16
BNO Bionomics Strengthens Board-BNO.AX 16/06/16
BNO Appendix 3B-BNO.AX 15/06/16
BNO Appendix 3B-BNO.AX 06/05/16
BNO Bionomics Corporate Presentation May 2016-BNO.AX 03/05/16
BNO Appendix 4C - quarterly-BNO.AX PRICE SENSITIVE29/04/16
BNO BNC105 Cancer Immune Activation Data Presented at AACR-BNO.AX PRICE SENSITIVE20/04/16
BNO Update on Board Recruitment Process-BNO.AX 14/04/16
BNO Change in substantial holding-BNO.AX 08/04/16
BNO Bionomics Initiates Phase 1 Study of BNC101-BNO.AX PRICE SENSITIVE04/04/16
BNO Notice Under Section 203D16/03/16
BNO Appendix 3B10/03/16
BNO Bionomics to Present at Upcoming U.S. Investor Conferences08/03/16
BNO Shareholder Consultation Process07/03/16
BNO Results of Meeting04/03/16
BNO Results of Meeting03/03/16
BNO For Further Information, Black Scholes Valuation25/02/16
BNO Half Yearly Report and AccountsPRICE SENSITIVE18/02/16
BNO Board Update17/02/16
BNO Becoming a substantial holder from CVC04/02/16
BNO Notice of Extraordinary General Meeting/Proxy Form01/02/16
BNO Becoming a substantial holder (revised form)
08/06/17
BNO Becoming a substantial holder
08/06/17
BNO Ceasing to be a substantial holder
07/06/17
BNO Bionomics Corporate Presentation May 2017
31/05/17PRICE SENSITIVE
BNO Bionomics NOW Newsletter May 2017
29/05/17
BNO Bionomics Recruits International Executive as CFO
24/05/17
BNO BNC210 Clinical Data Presented at US Psychiatry Convention
18/05/17PRICE SENSITIVE
BNO Bionomics to Host KOL Meeting Focused on BNC210 in London
10/05/17
BNO Appendix 4C - quarterly
26/04/17PRICE SENSITIVE
BNO Bionomics Presents Promising BNC101 Data at AACR Conference
03/04/17
BNO Webcast Available of KOL Meeting
24/03/17
BNO Bionomics to Host KOL Meeting on PTSD & Anxiety in New York
20/03/17
BNO Appendix 3B
13/03/17
BNO Bionomics to Present at 29th Annual ROTH Conference
10/03/17
BNO Ceasing to be a substantial holder from CVC
24/02/17
BNO Change in substantial holding
24/02/17
BNO Becoming a substantial holder
24/02/17
BNO Change in substantial holding
24/02/17
BNO New BNC105 Clinical Trial in Combination with Keytruda
20/02/17PRICE SENSITIVE
BNO Half Yearly Report and Accounts
17/02/17PRICE SENSITIVE
BNO MSD Cognition Program Milestone Payment
03/02/17PRICE SENSITIVE
BNO Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
BNO Bionomics Presents at Biotech Showcase 2017
09/01/17
BNO Appendix 3B
12/12/16
BNO Warrants Update
12/12/16
BNO Change of Director's Interest Notice
28/11/16
BNO Change of Director's Interest Notice
28/11/16
BNO Change of Director's Interest Notice
28/11/16
BNO Change of Director's Interest Notice
28/11/16
BNO Change of Director's Interest Notice
28/11/16
BNO Appendix 3B
28/11/16
BNO Appendix 3B
16/11/16
BNO BNO to Present at Society for Neuroscience Annual Meeting
16/11/16
BNO Final Director's Interest Notice
10/11/16
BNO Results of Meeting
08/11/16
BNO CEO & Managing Director's Report to Shareholders
08/11/16PRICE SENSITIVE
BNO Chairman's Address Bionomics Annual General Meeting 2016
08/11/16
BNO Appendix 3B
04/11/16
BNO Bionomics and MSD Annual Symposium
04/11/16
BNO Appendix 4C - quarterly-BNO.AX
31/10/16PRICE SENSITIVE
BNO BNO to Present at International Biotechnology Symposium-BNO.AX
25/10/16
BNO Upcoming Investor Presentations-BNO.AX
24/10/16
BNO Appendix 4G / Corporate Governance Statement-BNO.AX
07/10/16
BNO Bionomics Annual Report 2016-BNO.AX
07/10/16
BNO Notice of General Meeting/Proxy Form-BNO.AX
07/10/16
BNO Change of Director's Interest Notice-BNO.AX
06/10/16
BNO Appendix 3B-BNO.AX
06/10/16
BNO BNO to Present at Ladenburg Thalmann Healthcare Conference-BNO.AX
26/09/16
BNO BNO BNC210 GAD Trial Results Investor Call Replay-BNO.AX
22/09/16
BNO Positive BNC210 Phase 2 Anxiety Trial Results-BNO.AX
21/09/16PRICE SENSITIVE
BNO Trading Halt-BNO.AX
19/09/16PRICE SENSITIVE
BNO BNC210 Data to be Presented at ECNP-BNO.AX
16/09/16PRICE SENSITIVE
BNO Change of Director's Interest Notice-BNO.AX
15/09/16
BNO BNO to Present at Rodman & Renshaw Global Investment Conf.-BNO.AX
12/09/16
BNO Change of Director's Interest Notice-BNO.AX
01/09/16
BNO Final Director's Interest Notice-BNO.AX
01/09/16
BNO Initial Director's Interest Notice-BNO.AX
01/09/16
BNO Bionomics Appoints Alan Fisher Non-Executive Director-BNO.AX
31/08/16
BNO Change in substantial holding-BNO.AX
28/08/16
BNO Change in substantial holding-BNO.AX
26/08/16
BNO Appendix 3B-BNO.AX
19/08/16
BNO Appendix 3Y-BNO.AX
19/08/16
BNO Change of Director's Interest Notice-BNO.AX
17/08/16
BNO Withdrawal of Intention to Call General Meeting,CVC-BNO.AX
15/08/16
BNO Board Changes and Conclusion of Governance Review-BNO.AX
09/08/16
BNO Full Year Statutory Accounts-BNO.AX
09/08/16
BNO Bionomics 2015/2016 Preliminary Final Results-BNO.AX
09/08/16PRICE SENSITIVE
BNO Board and Shareholder Meetings-BNO.AX
03/08/16
BNO Appendix 4C - quarterly-BNO.AX
29/07/16PRICE SENSITIVE
BNO Bionomics to present at upcoming US Investor Conference-BNO.AX
12/07/16
BNO Final Director's Interest Notice-BNO.AX
08/07/16
BNO Appendix 3B-BNO.AX
04/07/16
BNO Director Retirement and Informal Board-Shareholder Meetings-BNO.AX
04/07/16
BNO Appendix 3B-BNO.AX
30/06/16
BNO BNO To Trial Drug Against Post-Traumatic Stress Disorder-BNO.AX
30/06/16PRICE SENSITIVE
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX
24/06/16PRICE SENSITIVE
BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX
24/06/16PRICE SENSITIVE
BNO Bionomics Receives Share of Funds from CTx License Deal-BNO.AX
23/06/16PRICE SENSITIVE
BNO Initial Director's Interest Notice-BNO.AX
21/06/16
BNO Initial Director's Interest Notice-BNO.AX
21/06/16
BNO Bionomics Strengthens Board-BNO.AX
16/06/16
BNO Appendix 3B-BNO.AX
15/06/16
BNO Appendix 3B-BNO.AX
06/05/16
BNO Bionomics Corporate Presentation May 2016-BNO.AX
03/05/16
BNO Appendix 4C - quarterly-BNO.AX
29/04/16PRICE SENSITIVE
BNO BNC105 Cancer Immune Activation Data Presented at AACR-BNO.AX
20/04/16PRICE SENSITIVE
BNO Update on Board Recruitment Process-BNO.AX
14/04/16
BNO Change in substantial holding-BNO.AX
08/04/16
BNO Bionomics Initiates Phase 1 Study of BNC101-BNO.AX
04/04/16PRICE SENSITIVE
BNO Notice Under Section 203D
16/03/16
BNO Appendix 3B
10/03/16
BNO Bionomics to Present at Upcoming U.S. Investor Conferences
08/03/16
BNO Shareholder Consultation Process
07/03/16
BNO Results of Meeting
04/03/16
BNO Results of Meeting
03/03/16
BNO For Further Information, Black Scholes Valuation
25/02/16
BNO Half Yearly Report and Accounts
18/02/16PRICE SENSITIVE
BNO Board Update
17/02/16
BNO Becoming a substantial holder from CVC
04/02/16
BNO Notice of Extraordinary General Meeting/Proxy Form
01/02/16
refresh Created with Sketch. REFRESH
 

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.